Fosun Pharma (02196) has granted a total of 453.51 million A-share options.

Intelligent Financial News App, Fosun Pharma (02196) announced that, considering that 6 of the first-time incentive recipients determined in the 2025 A-share stock options incentive plan are no longer working within the group and no longer belong to the scope of incentive recipients of this incentive plan, according to the authorization of the shareholders' meeting, approved by the board of directors, verified by the board of directors' remuneration and assessment committee, the list of first-time incentive recipients and the number of A-share options involved have been adjusted: the number of first-time incentive recipients has been adjusted from 201 to 195, and the number of A-share options initially granted has been adjusted from 4.5809 million to 4.5351 million.